Triumvira is a Texas-based biopharmaceutical company that researches and develops T-cell immunotherapy for the treatment of cancer and infectious diseases.
BioSpace selected 25 promising biotech startups for 2021, with Sana Biotechnology, EQRx, Nuvation Bio, ArsenalBio, and Triumvira Immunologics in the top 5.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.